US Bancorp
ZOM

US Bancorp’s Zomedica Corp. ZOM Stock Holding History

US Bancorp’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,750
Closed -$930 – 4425
2024
Q4 		$930 Hold
7,750
– – ﹤0.01% 3964
2024
Q3 		$1.06K Buy
+7,750
New +$1.09K ﹤0.01% 3890
2021
Q4 		– Sell
-10,000
Closed -$5K – 4321
2021
Q3 		$5K Hold
10,000
– – ﹤0.01% 3682
2021
Q2 		$8K Buy
+10,000
New +$9.32K ﹤0.01% 3507

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

US Bancorp's ZOM Position: Q1 2025 in Review

US Bancorp sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 7,750 shares — an estimated $930 sold.

US Bancorp first reported a position in ZOM in Q2 2021 and held it in 4 quarters. The position peaked at $8K in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • US Bancorp reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 7,750 Zomedica Corp. shares in Q1 2025, an estimated $930.
  • US Bancorp first reported a position in Zomedica Corp. in Q2 2021 and held it in 4 quarters.
  • US Bancorp's Zomedica Corp. position peaked at $8K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.